Latest Whitepapers

Flow cytometry is an important part of the drug discovery workflow. From screening antibodies to small molecules, combining tests for various analytes in a single panel not only reduces the necessary sample volume but also collects more information in less time, accelerating the drug discovery process.

Download this whitepaper to explore considerations when selecting a harvest technology such as sustainability, time and cost as well as space and scale.

Bioassays, such as the enzyme-linked bioabsorbant assay (ELISA), are standard techniques that require enzyme or fluorescent labels for the detection of target analytes. While these label-based studies give important information about a sample, such as binding affinity, they can only measure the interaction of an analyte at a given concentration and time, and are unable to gather kinetic analysis.

For the very first time since its publication, ACS Reagent Chemicals is now available online in a seamless, searchable database. If you are a producer of pharmaceuticals, download this whitepaper to learn how this invaluable resource can benefit your organization.

Small molecule drugs have formed most pharmaceutical discoveries for over a century, however, approximately 40% of current active pharmaceutical ingredients (APIs) are poorly soluble, along with around 90% of drugs in development.

Reliable and accurate pH measurement is highly dependent upon both the design and manufactured quality of the pH electrode, and is critical for assessing sensitive samples in industries such as biotechnology, pharmaceutical and food.

Download this whitepaper to review the exciting technology behind the advances in data independent acquisition and explore how it can enhance your research.

Today’s digital environment requires a scientifically aware informatics foundation that integrates critical capabilities with existing systems and information sources, speeding “science to compliance” for organizations that rely on scientific innovation to differentiate themselves.

This whitepaper highlights the key principles of mitochondrial toxicity assessment during drug discovery. It features customized assay solutions and the latest cell energy phenotyping technology.

Many novel cell and gene therapies have the potential to offer personalized therapeutic approaches and hold great promise for curing or treating diseases.